Literature DB >> 16352557

Inactivation of prions by acidic sodium dodecyl sulfate.

David Peretz1, Surachai Supattapone, Kurt Giles, Julie Vergara, Yevgeniy Freyman, Pierre Lessard, Jiri G Safar, David V Glidden, Charles McCulloch, Hoang-Oanh B Nguyen, Michael Scott, Stephen J Dearmond, Stanley B Prusiner.   

Abstract

Prompted by the discovery that prions become protease-sensitive after exposure to branched polyamine dendrimers in acetic acid (AcOH) (S. Supattapone, H. Wille, L. Uyechi, J. Safar, P. Tremblay, F. C. Szoka, F. E. Cohen, S. B. Prusiner, and M. R. Scott, J. Virol. 75:3453-3461, 2001), we investigated the inactivation of prions by sodium dodecyl sulfate (SDS) in weak acid. As judged by sensitivity to proteolytic digestion, the disease-causing prion protein (PrPSc) was denatured at room temperature by SDS at pH values of < or =4.5 or > or =10. Exposure of Sc237 prions in Syrian hamster brain homogenates to 1% SDS and 0.5% AcOH at room temperature resulted in a reduction of prion titer by a factor of ca. 10(7); however, all of the bioassay hamsters eventually developed prion disease. When various concentrations of SDS and AcOH were tested, the duration and temperature of exposure acted synergistically to inactivate both hamster Sc237 prions and human sporadic Creutzfeldt-Jakob disease (sCJD) prions. The inactivation of prions in brain homogenates and those bound to stainless steel wires was evaluated by using bioassays in transgenic mice. sCJD prions were more than 100,000 times more resistant to inactivation than Sc237 prions, demonstrating that inactivation procedures validated on rodent prions cannot be extrapolated to inactivation of human prions. Some procedures that significantly reduced prion titers in brain homogenates had a limited effect on prions bound to the surface of stainless steel wires. Using acidic SDS combined with autoclaving for 15 min, human sCJD prions bound to stainless steel wires were eliminated. Our findings form the basis for a noncorrosive system that is suitable for inactivating prions on surgical instruments, as well as on other medical and dental equipment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16352557      PMCID: PMC1317507          DOI: 10.1128/JVI.80.1.322-331.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

1.  Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie.

Authors:  C J Gibbs; D C Gajdusek; R Latarjet
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

2.  Encephalopathy in mice produced by inoculation with scrapie brain material.

Authors:  R L CHANDLER
Journal:  Lancet       Date:  1961-06-24       Impact factor: 79.321

3.  Advances in veterinary research.

Authors:  W S GORDON
Journal:  Vet Rec       Date:  1946-11-23       Impact factor: 2.695

4.  Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da.

Authors:  C G Bellinger-Kawahara; E Kempner; D Groth; R Gabizon; S B Prusiner
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

5.  Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids.

Authors:  C Bellinger-Kawahara; T O Diener; M P McKinley; D F Groth; D R Smith; S B Prusiner
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

6.  Infectivity of scrapie prions bound to a stainless steel surface.

Authors:  E Zobeley; E Flechsig; A Cozzio; M Enari; C Weissmann
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

7.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

8.  Transmission barriers for bovine, ovine, and human prions in transgenic mice.

Authors:  Michael R Scott; David Peretz; Hoang-Oanh B Nguyen; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

9.  Strain-specified characteristics of mouse synthetic prions.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; Ilia V Baskakov; Fred E Cohen; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

10.  Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.

Authors:  S B Prusiner; D F Groth; S P Cochran; F R Masiarz; M P McKinley; H M Martinez
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

View more
  41 in total

1.  Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.

Authors:  Sotirios Botsios; Sarah Tittman; Laura Manuelidis
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 2.  Bioassays and Inactivation of Prions.

Authors:  Kurt Giles; Amanda L Woerman; David B Berry; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

3.  Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.

Authors:  Alexandra R Chesney; Clarissa J Booth; Christopher B Lietz; Lingjun Li; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2016-06-20       Impact factor: 9.028

4.  MSA prions exhibit remarkable stability and resistance to inactivation.

Authors:  Amanda L Woerman; Sabeen A Kazmi; Smita Patel; Yevgeniy Freyman; Abby Oehler; Atsushi Aoyagi; Daniel A Mordes; Glenda M Halliday; Lefkos T Middleton; Steve M Gentleman; Steven H Olson; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2017-08-28       Impact factor: 17.088

5.  Identification of I137M and other mutations that modulate incubation periods for two human prion strains.

Authors:  Kurt Giles; Gian Felice De Nicola; Smita Patel; David V Glidden; Carsten Korth; Abby Oehler; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

6.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

7.  Kinetics of ozone inactivation of infectious prion protein.

Authors:  Ning Ding; Norman F Neumann; Luke M Price; Shannon L Braithwaite; Aru Balachandran; Gordon Mitchell; Miodrag Belosevic; Mohamed Gamal El-Din
Journal:  Appl Environ Microbiol       Date:  2013-02-15       Impact factor: 4.792

Review 8.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

9.  PrP expression level and sensitivity to prion infection.

Authors:  Jean-Yves Douet; Caroline Lacroux; Fabien Corbière; Claire Litaise; Hugh Simmons; Séverine Lugan; Pierrette Costes; Hervé Cassard; Jean-Louis Weisbecker; François Schelcher; Olivier Andreoletti
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie.

Authors:  Andrea M Deleault; Nathan R Deleault; Brent T Harris; Judy R Rees; Surachai Supattapone
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.